Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

122.11
Delayed Data
As of 3:59pm ET
 -2.98 / -2.38%
Today’s Change
96.18
Today|||52-Week Range
145.42
-0.20%
Year-to-Date
John Paulson Buys T-Mobile US Inc, DISH Network Corp, Mead Johnson Nutrition Co, Sell...
Jun 26 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug
Jun 15 / Zacks.com - Paid Partner Content
Top Stock Reports for Oracle, Allergan & Abbott
Jun 23 / Zacks.com - Paid Partner Content
Omeros (OMER) Lead Candidate Gets Breakthrough Designation
Jun 14 / Zacks.com - Paid Partner Content
Biotech Insider Just Loaded Up $234 Million Worth the Stock
Jun 21 / TheStreet.com - Paid Partner Content
Biogen Loses Top Executive Again, CFO Clancy to Join Alexion
Jun 14 / Zacks.com - Paid Partner Content
Company News for June 15, 2017
Jun 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close125.09
Today’s open125.20
Day’s range122.00 - 126.39
Volume2,834,578
Average volume (3 months)2,768,240
Market cap$28.1B
Dividend yield--
Data as of 3:59pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+14.88%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+21.11%
P/E ratio58.1
Price/Sales9.22
Price/Book3.22

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp-4.36-3.24%
ZTSZoetis Inc+0.04+0.06%
BAXBaxter International...-0.29-0.48%
VRTXVertex Pharmaceutica...-4.18-3.13%
Data as of 4:00pm ET, 06/27/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$1.25
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts